| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Iridex Corporation (IRIX) have been net buyers, picking up 14,975 shares worth roughly $16K on balance.
IRIX sits in the Health Care Equipment & Supplies industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 551.4K | $458.0K | - | |
| CEO | 368.8K | $306.3K | - | |
| Dir | 251.6K | $208.9K | - | |
| CFO | 133.3K | $110.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2016 | Dizon Romeo R64 | Principal Accounting Officer | Sale+OE | 875 | $14.52 | $12,707.98 | -4.2% | |
| Aug 19, 2016 | Dizon Romeo R64 | Principal Accounting Officer | Sale+OE | 7,896 | $13.52 | $106,733.96 | -3.8% | |
| Aug 16, 2016 | Marcellino George R | Director | Sell | 2,513 | $13.57 | $34,101.91 | -66.1% | |
| Aug 16, 2016 | Dizon Romeo R64 | Principal Accounting Officer | Sell | 839 | $13.70 | $11,494.30 | -4.0% | |
| Jun 6, 2016 | Steckel Ronald | VP, Operations | Sale+OE | 625 | $13.52 | $8,448.00 | -0.9% | |
| May 17, 2016 | Steckel Ronald | VP, Operations | Sale+OE | 4,583 | $12.81 | $58,717.73 | -2.2% | |
| Mar 8, 2016 | Steckel Ronald | VP, Operations | Sale+OE | 12,000 | $10.45 | $125,406.00 | -5.5% | |
| Nov 19, 2015 | Moore William M80 | Chairman And CEO | Buy | 10,000 | $9.83 | $98,326.00 | +3.6% | |
| Sep 25, 2015 | Paragon Associates & Paragon Associates II Joint Venture | 10% Owner | Buy | 52,042 | $7.05 | $366,867.32 | +1.4% | |
| Sep 10, 2015 | Paragon Associates & Paragon Associates II Joint Venture | 10% Owner | Buy | 11,866 | $6.95 | $82,417.46 | +0.5% |